Home › Oligodendroglioma
Oligodendroglioma clinical trials recruiting in the U.S.
15 studies for Oligodendroglioma are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX4 studies
- Boston, MA3 studies
- Miami, FL3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
By state
Recently updated studies
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 14, 2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
RecruitingPhase 1/2
Ages 2 to 24 · All sexes · Updated Sep 11, 2026 · NCT04923126FearLess in NeuroOncology
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06989086HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT04623931Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07468136ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
RecruitingPhase 1
Ages 18 to 89 · All sexes · Updated May 27, 2026 · NCT06254326Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT07462507All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT05345002Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RecruitingPhase 1/2Healthy volunteers welcome
Ages 1 to 21 · All sexes · Updated Dec 8, 2025 · NCT05956821HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Recruiting
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06930846Implantable Microdevice In Primary Brain Tumors
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 23, 2025 · NCT04135807From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.